Projected impact of treatment intensification with statin, ezetimibe, and statin plus ezetimibe fixed-dose combination on MACE across six countries.

Michel Farnier Raul Dias Dos Santos Filho Juan Cosín Sales Marat V EzhovJian LiuDenis Granados Serena Santoni Irfan Khan Alberico Luigi Catapano

Published in: European journal of preventive cardiology (2022)

The 2019 ESC/EAS guideline-based treatment intensification with strategies based on statin, ezetimibe, and statin plus ezetimibe FDC is estimated to result in a substantial population-level benefit in terms of MACE averted compared with BAU.

Keyphrases

cardiovascular disease
coronary artery disease
climate change
combination therapy